Innovative Cellular Therapeutics Holdings Ltd
CIK: 0002095697
Associated companies
Transaction History
| LYEL | ▼ Sell | Other | 44,000 | $0 | 7/27/2026 | View on chart |
| LYEL | ▼ Sell | Other | 38,500 | $0 | 7/27/2026 | View on chart |
| LYEL | ▼ Sell | Open Market | 10 | $137 | 7/17/2026 | View on chart |
| LYEL | ▼ Sell | Open Market | 10 | $137 | 7/16/2026 | View on chart |
| LYEL | ▼ Sell | Other | 76,000 | $0 | 6/29/2026 | View on chart |
| LYEL | ▼ Sell | Other | 66,500 | $0 | 6/15/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Lyell Immunopharma shares fall 27% over four weeks
The stock has dropped about 27% in the past month, prompting a Yahoo article that discusses factors that could support a recovery. The piece notes the recent price weakness and points to potential catalysts that may improve sentiment. The decline leaves the share price near a key support level and the RSI is low, indicating oversold conditions.
Lyell Immunopharma shares fall 27% over four weeks. The stock has dropped about 27% in the past month, prompting a Yahoo article that discusses factors that could support a recovery. The piece notes the recent price weakness and points to potential catalysts that may improve sentiment. The decline leaves the share price near a key support level and the RSI is low, indicating oversold conditions.